Issues

In the latest issue of Clinical Science (volume 133, issue 11), Sun et al. elucidate the role of junctional molecule-like protein (JAML) in atherosclerosis, and discuss the protein’s potential as a therapeutic drug to attenuate atherogenesis. This cover features representative confocal co-immunofluorescence staining for JAML, showing strong JAML (red) expression in the macrophages (green) of atherosclerotic plaque from human coronary artery.